HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne)

计划入组 25 人 · 首次发布于 2015 年 6 月 30 日

A Study in Asymptomatic HIV Infected Patients to Investigate Pharmacodynamics, Pharmacokinetics, Safety and Toleration of UK-453,061

计划入组 49 人 · 首次发布于 2006 年 7 月 6 日

Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms

计划入组 27 人 · 首次发布于 2006 年 12 月 8 日

UK-157147

UK-383367

UK-37-248

ALCOHOL RESEARCH UK

United Kingdom

ASTRAZENECA UK LIMITED

United Kingdom

EUROAPI UK LIMITED

United Kingdom

FDA Clears IND for Myogenica's MyoPAXon in Duchenne Muscular Dystrophy

Santhera's Agamree Receives NICE Recommendation and China NMPA Approval for Duchenne Muscular Dystrophy Treatment

MetrioPharm's MP1032 Receives FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Treatment